Chimeric Antigen Receptor T Cell–Mediated Neurotoxicity in Nonhuman Primates

Authors:

Abstract
Chimeric antigen receptor (CAR) T-cell immunotherapy has revolutionized the treatment of refractory leukemias and lymphomas, but is associated with significant toxicities, namely cytokine release syndrome (CRS) and neurotoxicity. A major barrier to developing therapeutics to prevent CAR T cell–mediated neurotoxicity is the lack of clinically relevant models. Accordingly, we developed a rhesus macaque (RM) model of neurotoxicity via adoptive transfer of autologous CD20-specific CAR T cells. Following cyclophosphamide lymphodepletion, CD20 CAR T cells expand to 272 to 4,450 cells/μL after 7 to 8 days and elicit CRS and neurotoxicity. Toxicities are associated with elevated serum IL6, IL8, IL1RA, MIG, and I-TAC levels, and disproportionately high cerebrospinal fluid (CSF) IL6, IL2, GM-CSF, and VEGF levels. During neurotoxicity, both CD20 CAR and non-CAR T cells accumulate in the CSF and in the brain parenchyma. This RM model demonstrates that CAR T cell–mediated neurotoxicity is associated with proinflammatory CSF cytokines and a pan–T cell encephalitis. Significance: We provide the first immunologically relevant, nonhuman primate model of B cell–directed CAR T-cell therapy–mediated CRS and neurotoxicity. We demonstrate CAR and non-CAR T-cell infiltration in the CSF and in the brain during neurotoxicity resulting in pan-encephalitis, accompanied by increased levels of proinflammatory cytokines in the CSF. Cancer Discov; 8(6); 750–63. ©2018 AACR. This article is highlighted in the In This Issue feature, p. 663
Funding Information
  • HHS | NIH | National Cancer Institute (NCI) (P01CA065493)
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) (1UM1AI126617)
  • HHS | NIH | National Institute of Child Health and Human Development (NICHD) (U19AI117945)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) (R33AI116184)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) (1R01HL095791)
  • St. Baldrick's Foundation
  • Conquer Cancer Foundation (CCF)
  • ASBMT
  • HHS | NIH | National Institute of Child Health and Human Development (NICHD) (2U19AI051731)
  • NIH Ruth L. Kirschstein NRSA Training Grant (T32CA009351)
  • HHS | NIH | National Cancer Institute (NCI) (R01CA136551)
  • University of Washington Cancer Consortium/CCSG (P30CA015704)

This publication has 41 references indexed in Scilit: